María del Mar
Castellanos Rodrigo
Instituto de Investigación Sanitaria Biobizkaia
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (9)
2024
-
A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950
-
Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study
Neurologia
2022
-
Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology
Neurologia, Vol. 37, Núm. 1, pp. 61-72
2021
-
Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis
Journal of Clinical Medicine, Vol. 10, Núm. 14
-
Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma
Brain, Vol. 144, Núm. 8, pp. 2416-2426
-
Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group
Neurologia, Vol. 36, Núm. 6, pp. 462-471
2020
-
Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain
European Journal of Neurology, Vol. 27, Núm. 12, pp. 2491-2498
-
Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain
International Journal of Stroke, Vol. 15, Núm. 7, pp. 755-762
-
Oral Anticoagulation and Risk of Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Mechanical Thrombectomy: Data From the Nordictus Registry
Frontiers in Neurology, Vol. 11